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An ovarian bioreactor for in vitro culture of
the whole bovine ovary: a preliminary
report
Matthew R. Zanotelli1†, Joseph D. Henningsen1†, Patrick M. Hopkins1†, Aaron P. Dederich1†, Tessa Herman2,
Tracy J. Puccinelli1 and Sana M. Salih2,3*
Abstract
Background: Improved cancer therapeutics and enhanced cancer survivorship have emphasized the severe
long-term side effects of chemotherapy. Specifically, studies have linked many chemotherapy agents with primary
ovarian insufficiency, although an exact insult model has not yet been determined. To investigate and ultimately
solve this problem, a novel device for extended study of mammalian ovaries in vitro was developed.
Methods: A bioreactor was fabricated for bovine ovarian culture that provides intravascular delivery of media to
the ovary through isolation and cannulation of a main ovarian artery branch. Whole ovaries were cultured in vitro
using three methods: (1) continuously supplied fresh culture media, (2) recirculated culture media, or (3) continuously
supplied fresh culture media supplemented with 500 nM doxorubicin for 24 or 48 h. TUNEL assay was used to assess
apoptotic cell percentages in the three groups as compared to uncultured baseline ovaries.
Results: The ovary culture method was shown to maintain cell viability by effectively delivering nutrient-enriched
pH-balanced media at a constant flow rate. Lower apoptosis observed in ovaries cultured in continuously supplied
fresh culture media illustrates that this culture device and method are the first to sustain whole bovine ovary viability
for 48 h. Meanwhile, the increase in the percentage of cell apoptosis with doxorubicin treatment indicates that the
device can provide an alternative model for testing chemotherapy and chemoprotection treatments to prevent
primary ovarian insufficiency in cancer patients.
Conclusions: An ovarian bioreactor with consistent culture media flow through an ovarian vasculature-assisted
approach maintains short-term whole bovine ovary viability.
Keywords: Ovary, Ovary culture, Bovine ovary, Bioreactor, Ovarian insufficiency, Infertility, Doxorubicin, Chemotherapy,
Apoptosis, Granulosa cell
Background
While innovations in cancer chemotherapy allow
patients to live longer, they also have been shown to lead
to subsequent long-term complications, such as primary
ovarian insufficiency (POI) [1]. POI has a pronounced
effect on younger patients in particular, and can result in
failure of pubertal development and complete sterility
[2]. Further complications have also been associated with
POI, including onset of osteoporosis and cardiovascular
disease [2, 3]. These factors provide motivation to
determine the cellular cause of chemotherapy-induced
POI and develop drug-based measures to inhibit its de-
velopment in cancer patients.
Doxorubicin (DXR) is a chemotherapy drug used to
treat premenopausal cancer patients in combination with
other chemotherapy protocols and has been associated
with POI [4]. The effects of DXR have been documented
in mice as well as marmoset ovaries including DNA dam-
age within 2 h, follicular attrition in as little as 12 h post-
injection, and permanent reduction in ovary size up to
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50 % [5–7]. While embryo and oocyte cryopreservation
are used to preserve fertility in reproductively-mature
women [8], current methods of prevention of DXR and
other chemotherapy-induced ovarian toxicity in young fe-
male cancer survivors, however, remain challenging.
Methods of fertility preservation in female children and
young adolescents include ovarian cortical tissue cryo-
preservation, an invasive and an experimental procedure
[9–11]. Fertility preservation in children is in its develop-
mental stages due to insufficient understanding of the
mechanism of ovarian insult [12]. Whole ovary cryo-
preservation, in vitro follicle maturation, and ovarian
chemoprotective drugs are also still investigational
[13–22]. Further research into the mechanisms of
ovarian insult could lead to more effective methods
of prevention of POI during chemotherapies [20, 21].
The mechanisms behind DXR toxicity remain
poorly understood. One tool to identify and study
mechanisms of ovarian insult is organ culture. Most
model systems for organ culture utilize bioreactors, as
bioreactors have the unique ability to sustain large-
scale cell viability as well as enable tissue-specific ex-
perimentation. Organ bioreactors have been success-
fully developed, though not yet for ovaries. Systems
for isolating lungs, livers, and kidneys of large animals
are commercially available and have been shown to
be highly beneficial in a research setting [23–27]. In a
successful organ culture, cells must be supplied with
sufficient nutrition to proliferate. This is achieved
with the flow of culture medium into/around the cells
or tissue. Ideally, a bioreactor will meticulously con-
trol and monitor parameters that affect cell culture
efficiency, namely: pH, temperature, flow rate, mech-
anical stresses, and biochemical gradients, to achieve
an optimal culture environment. Whole ovaries have
been preserved for up to 48 h under conditions that
do not replicate the in vivo environment, but a whole
ovary bioreactor has not been studied [28–30].
Herein, we report the design and development of a
custom bioreactor for the extended culture of bovine
ovaries for 48 h. This timeline was chosen to corrob-
orate our previous mice studies where acute DXR-
induced follicle apoptosis occurring within 48 h
correlates with decreased fertility and reduced litter
size and number throughout the reproductive lifespan
of the mice [20]. Utilizing the existing ovarian vascu-
lature, culture media was administered throughout
the ovaries, and the supply of nutrients was coupled
with an incubator to mimic the in vivo environment.
Altogether, the system enables administration of nu-
trients to maintain ovarian viability, enables the intro-
duction of DXR into the ovary to effectively study the
mechanism by which ovarian insult occurs, and allows
validation of putative chemoprotective drugs.
Methods
Ovary tissue acquisition
Bovine ovaries were obtained from the local abattoir
through Applied Reproductive Technologies (Madison,
WI) and transported at room temperature immediately
to the laboratory. Three ovaries with pronounced vascu-
lature were selected for each experiment. Selected ovar-
ies were stored in 1X warmed phosphate buffered saline
(PBS) (Mediatech, Inc.) until use. The University of
Wisconsin - Madison approved all proceeding procedure
prior to implementation.
Bioreactor fabrication and assembly
To create a sterile, controllable environment to promote
ovary maturation, a bioreactor was designed. Figure 1
demonstrates the whole ovary culture system. The ovary
bioreactor was constructed from a 1000 mL Duran
GLS 80 wide-mouth laboratory bottle (Sigma-Aldrich)
(Fig. 1d) with a customized cap to accommodate inte-
gration with a pump. Two 1/4″ ports were drilled
and tapped to provide inlet and outlet ports. Within
the ports, the top of the bottle cap was fitted with 1/4″
polypropylene barbed hose adapters with 1/8″ female
national pipe threads (NPT) threads (US Plastics, Lima,
OH). The underside of the cap was equipped with 1/4″
polypropylene barbed hose adapters with 1/8″ female
NPT threads (US Plastics) (Fig. 1b). Three 1/8″ holes
were also drilled and tapped. Two of these holes were
used as support for the ovary holder described below, and
the third was to be fitted with a 0.22 μm air filter
(Millipore) to allow diffusion of oxygen and carbon diox-
ide. Two additional bottles were customized in a similar
fashion to serve as a fresh media reservoir and a waste
media reservoir. For the reservoir bottles, each bottle cap
had a single 1/4″ port drilled, tapped, and fitted with 1/4″
polypropylene threaded adapters and 1/8″ female NPT
threads (US Plastics). Adapters were then connected to an
8-channel, ten rollers multi-channel peristaltic pump
(Langer Instruments, model BT100-1 L) by 2250 1/8″ x
3/16″ laboratory tubing (Tygon) (Fig. 1e). The inflow loop
of the system created flow from the fresh media reservoir
to the bioreactor while the outflow circuit of the system
removed perfused media from the ovary in the bioreactor
to the waste media reservoir.
To provide support to the ovary inside the bioreactor
and collect waste media, a customized polypropylene
container was created (Fig. 1c). This container will be
referred to as the ovary holder. To construct the ovary
holder, a polypropylene sheet (MSC Direct) was milled
using a Tormach p770 CNC mill (Fig. 1c). Using the
CNC mill, the sheet was cut into a 2.36″ diameter cylin-
der that has a height of 1.50.″ From one face of the
cylinder, a cone shape was removed from the center of
the face to create a funnel. The cone removed from the
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cylinder was cut at 58° to the horizontal with a base
diameter of 0.91″ and height of 1.25.″ This created the
funnel which could comfortably hold a bovine ovary
which is typically bean-shaped and roughly 2.0 cm x
1.5 cm. A 0.25″ diameter hole was drilled into the tip of
the funnel to allow for any perfused fluid to flow out of
the ovary and then exit the funnel. On the outside edge
of the holder, two 1/8″ holes were drilled and tapped.
Nylon rods measuring 180 mm were securely fitted and
attached to the corresponding 1/8″ holes in the cap to
suspend the ovary holder in the bottle. This allowed the
ovary to be partially submerged in media during culture.
To guide the outflow tube to the waste media located in
the bottom of the bioreactor, an additional 1/4″ hole
was drilled and tapped through the outer lip of the ovary
holder.
Ovary cannulation and preparation
All ovaries received were used for perfusion for the initial
flow rates studies independent of whether the ovary was in
the follicular or luteal phase while only ovaries in the
follicular phase were used for the terminal deoxynucleotidyl
transferase dUTP nick end labeling (TUNEL) assay. The
procedure used for cannulation was modeled from the
Fig. 1 Ovarian bioreactor components and schematic of bioreactor setup. a Ovaries were first cannulated and tied off using suture. Ovaries were
then placed in a customized bioreactor consisting of (b) a modified GLS 80 cap fitted with inlet and outlet ports for media flow and (c) a
polypropylene ovary holder. d All bioreactor components were housed in a 1000 mL bottle with short rods connecting the ovary holder to the
cap. e The entire bioreactor and media reservoir bottle were placed in an incubator to maintain an in vivo environment while the waste media
bottle was placed outside the incubator. A digital multi-channel pump controlled and maintained media flow into the ovary via the cannula
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techniques used for perfusion of bovine and ovine ovaries
in previous studies [12, 24]. The bovine ovarian artery
branches higher in the mesovarium and typically 2-3 arter-
ial branches were identified at the ovarian stump. Using
sterile scissors, all extraneous ovarian tissue surrounding
the vasculature was removed, leaving an approximately
5 cm stump with the ovarian vasculature remaining. A
prominent ovarian artery was located within the compact
nesting of vessels in the ovarian stump. The arteria ovarica
in the vascular pedicle was identified and prepared for per-
fusion (Fig. 1a). The artery was not completely skeletonized
as this was associated with arterial damage. The opening of
the isolated artery was secured, and a 23-gauge leur stub
(Instech Laboratories, Inc.) was inserted into the isolated
ovarian artery and tied off using a 6-0, Prolene suture
(Ethicon, US) to provide a sealed connection and prevent
backflow (Fig. 1a). The leur stub was then connected via a
luer adapter (Instech Laboratories, Inc.) to 1/8″ tubing
(Saint-Gobain Performance PLST), which was connected to
the cap and, in series, the multi-channel peristaltic pump.
Prior to experimentation, all tubing was first primed by
pumping 1X PBS (Mediatech, Inc.) through the tubing
and bioreactor until all air bubbles were eliminated from
the tubing and cap connections. The pump was calibrated
at a pressure that created a flow of 1.5 mL/min through
the tubing into atmospheric conditions. Sterile 1X PBS
was then pumped at this setting through the ovarian arter-
ial vasculature for three, 5 min washes. Cannulated and
washed ovaries were immediately used for testing.
Assessment of bioreactor functionality
As the experiment was to be performed with a custom
setup, the effectiveness of the bioreactor in delivering
fluid to the ovary was assessed. As a proof of concept,
water stained with trypan blue dye was placed in the
media reservoir and run through the cannulated ovarian
artery (see above). Measurements of ovary mass, fluid
inflow, and fluid outflow were recorded every two min
for 20 min of testing. After 10 and 60 min of the experi-
ment, an ovary was sectioned to observe qualitatively
the distribution of fluid throughout the vasculature and
ovary. The complete distribution of dyed water through
the vasculature and interstitial space of the ovary would
indicate that the system was distributing fluid to the
entire ovary over time and provide motivation for pro-
ceeding to the assessment of the setup during extended
culture of whole bovine ovaries.
Insulin-Transferrin-Selenium (ITS)
In vitro whole bovine ovary culture
To culture whole bovine ovaries with the system
described above, ovaries were placed on the specialized
polypropylene ovary holder with the leur stub oriented
vertically and housed in the bioreactor. The bioreactor
and fresh media reservoir were filled with 150 mL and
1000 mL, respectively, of Dulbecco’s modified Eagle’s
medium/Ham’s F-12 (HyClone) supplemented with 5 %
fetal bovine serum (Invitrogen), Insulin-Transferrin-
Selenium (Corning), and 5 U/mL penicillin/5 μg/mL
streptomycin (Gibco) [23]. The bioreactor and media
reservoirs were placed in an incubator to maintain a 39 °
C, 5 % CO2 environment while the pump and waste
media reservoirs were placed next the incubator. Utiliz-
ing the chamber thru-wall access port of the incubator,
tubing for all components of the system was connected
(Fig. 1). Ovaries were cultured in three conditions: (1)
continuous fresh media circulation (Group 1), (2) re-
circulation of used media (Group 2), and (3) DXR
treatment of continuous fresh media circulation (Group
3). To achieve continuous fresh media circulation (Group
1), media was pumped from the fresh media reservoir and
circulated through the ovarian arterial vasculature. Over
time, media slowly perfused throughout the entire ovary
and collected in the bottom of the bioreactor. Waste
media was transported from the bottom of the bioreactor
to the waste reservoir and discarded. A total of three res-
ervoirs including the ovary bioreactor were used. Recircu-
lation of used media (Group 2) was achieved by using two
reservoirs only, and recirculating media located at the base
of the bioreactor. Any media perfused from the ovary was
collected and recirculated through the ovarian arterial
vasculature. In the last experimental group, DXR treat-
ment (Group 3), ovaries were cultured using the same
methods as Group 1; however, culture was additionally
supplemented with 500 nM DXR. All ovaries were
partially submerged in 150 mL of media in the ovary
holder. In all experimental groups, the driving pressure
created by the pump was maintained at 1.5 mL/min under
atmospheric conditions and each ovary was allowed to
grow over for 2 days at 39 °C, 5 % CO2.
Assessment of bioreactor environment
At 6, 12, and 24 h the fluid volume in both the fresh and
waste media reservoirs was recorded. The difference in
fluid volume over time in the media reservoirs was used
to determine the average flow rate of the media over that
period using equation 1.
Q ¼ ΔV
ΔT
ð1Þ
Additionally, after 12, 24, and 48 h of culture, perfused
media from the ovary was collected from the waste
media reservoir, and pH measurements were taken to
assess the culture environment created by the ovary
bioreactor.
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Assessment of apoptotic cells in ovarian tissue
Immunohistochemistry was used to evaluate cellular apop-
tosis of ovarian tissue in the bioreactor system. Ovaries
were collected after 24 to 96 h of culture and each ovary
was divided into four quarters. Ovarian quarters were either
fixed directly in formalin or sliced further with the Stadie
Riggs Tissue Slicer to collect the superficial most layer of
the ovarian cortex and then ovarian tissue was fixed in
10 % buffered formalin (Fisher Chemical) at 4 °C for ~24 h.
Samples were then transferred to 70 % ethanol and stored
at 4 °C until paraffin embedding and mounting. Using a
microtome, samples were sliced into 5 μm sections, and a
minimum of three to ten representative sections per each
ovary were collected at least 25 μm intervals. Samples were
stained using the ApopTag Plus Fluorescein In Situ Apop-
tosis Detection Kit (EMD Millipore) [6] with slight modifi-
cations to the manufacturer protocol [26]. Briefly, an
additional pretreatment wash with 0.5 % Triton X-100 for
10 min was performed prior to applying equilibration buffer
and an additional six washes with Triton X-100 were
performed prior to mounting the slide. Cells undergoing
apoptosis were stained with fluorescein isothiocyanate
(FITC, green). All the nuclei were counterstained with
0.5 μg/mL propidium iodide (PI, red). Samples were imaged
using a Nikon TI Eclipse fluorescent microscope with a
motorized stage exciting/collecting at 488/525 nm for FITC
and 561/570-620 for PI. Spectral images acquired utilized
the spectral scan head on the A1 confocal, exciting at
488 nm and collecting emissions from 520 nm through
620 nm at 10 nm intervals [6].
Images were analyzed using Fiji (ImageJ software
version 1.47v) to calculate tunnel staining in the whole
ovarian sections. Images were converted to 8-bit binary
using the “Process–Binary–Make Binary” option. Then
utilizing the “Analyze–Analyze Particles” option (size
μm2: 20-Infinity, circularity: 0.00-1.00) individual feature
profiles of cells were counted within each image. This
allowed for the number of apoptotic cells and number of
total cells to be determined and used to calculate the
percent of total apoptotic cells. Additionally, manual
counting was used to assess TUNEL staining in the
ovary as well. Manual counting allowed the careful
inspection to identify ovarian structures and exclude
artifacts from FITC-positive staining of red blood cells
and non-nuclear staining. For manual quantification of
apoptosis in ovarian stroma and granulosa cells, grids
with100-μm2 squares were overlaid on the ovarian
image. TUNEL-positive ovarian cells per randomly se-
lected units of six squares (representing 600-μm2 areas)
were counted [31].
Statistical analysis
All experiments were carried out in three replicates with
three ovaries for each experiment (one ovary per treatment
type). All results are given as mean ± standard error.
Analysis of significance was performed using a two-way
ANOVA with Bonferroni tests for means comparisons
(mean ± SEM) with results considered statistically signifi-
cant if p < 0.05. Data were normalized to control to allow
pooling of experiments.
Results
Bioreactor system setup and functionality
To study the bioreactor system functionality and efficacy,
we examined fluid distribution through the ovarian tissue
over time. Qualitative comparison of the distribution of
water dyed with trypan blue after 10 min and 60 min to
uncultured control ovary demonstrated media distribution
across the entire ovary via the arterial vasculature (Fig. 2a).
These ovaries were not immersed in culture media to
exclude diffusion of the dye from the external medium to
the ovary. After 10 min of continuous flow, the ovarian
vasculature and interstitial space showed signs of trypan
blue staining, and after 60 min, fluid stained much of the
innermost ovarian tissue (Fig. 2a-c). Importantly, the ovar-
ian arterial vasculature remained intact in all ovaries tested.
Variation in dye distribution within the ovary was also ob-
served, as the density of the dye stained corpora lutea varies
between samples. This preliminary testing demonstrated
fluid distribution to the ovary via the ovarian vasculature
and warranted the progression to using culture media in
the system in an attempt to sustain ovary viability.
We next characterized mass changes and outflow rates
from the ovary to determine if tested ovaries were
absorbing administered nutrients. The average baseline
weight of bovine ovaries was 15.7 ± 2.2 g. Fluid flow into
the ovary was accompanied by a large increase in mass,
with the ovary increasing 6.28 ± 1.9 g in mass, compared
to 0 min, after 10 min. This accounts for a 40 % increase
in mass. Over the following 10 min; however, the rate of
mass increase slowed dramatically and only demon-
strated a 7.63 ± 3.1 g increase in mass by 20 min. This
accounts for a 48 % total increase, but only a 6 %
increase after 10 min (Fig. 2d). The flow of dye out of
the ovary exhibited a similar trend with an initially lower
outflow rate of 0.933 ± 0.22 mL/min at 2 min, followed
by an increased outflow rate of 1.83 ± 0.22 mL/min at
10 min, an ~97 % increase. Outflow also slowed, increas-
ing only to over the next 10 min with a 2.01 ± 0.21 mL/
min outflow rate at 20 min (Fig. 2e).
Ovary bioreactor culture environment
To assess the bioreactor environment, we examined flow
rate through the ovarian vasculature and pH of media.
During the whole ovary culture, the flow rate through
the ovarian vasculature of Group 1 was measured to be
constant at 0.86 ± 0.02 mL/min across all time points (6,
12 and 24 h) (Table 1). The flow rate of DXR-treated
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samples (Group 3) were also measured to be constant
with a mean of 0.88 ± 0.04 mL/min across time points
and was not significantly different from the ovaries in
Group 1 (Table 1). Flow rates for samples cultured in
recirculated media (Group 2) could not be measured in
the closed system. The pH readings of samples were
varied across experimental groups. The pH of waste
media from ovaries cultured with continuous fresh
media circulation (Group 1) remained consistent during
culture with a mean of 7.72 ± 0.04 across all time points
(12, 24, and 48 h) (Table 1). Similarly, the pH of the
waste media for Group 3 also remained constant 7.76 ±
0.14 across all time points (12, 24, and 48 h), similar to
Group 1 (Table 1). Samples cultured in recirculated
media (Group 2) showed a sharp decrease in pH, falling
at each observed time point and a mean value of 6.27 ±
0.51 across the 12, 24, and 48 h time points (Table 1).
Variation in both flow rate into the ovary and pH of the
media over time could have an effect on cell viability
during culture.
Fig. 2 Nutrient distribution across bovine ovaries. Stained water was run through the ovarian vasculature using our cannulation method at
1.5 mL/min, and ovaries were dissected (a) immediately following harvest, (b) 10 min of fluid flow testing, and (c) 60 min of fluid flow testing.
After extended flow, the ovarian vasculature and tissue became stained with trypan, demonstrating fluid was successfully administered via the
native vasculature. c Over short-term culture, whole ovary mass was observed to quickly increase, but began to slow at approximately 15 min,
indicating saturation (Logarithmic trendline, R2 = 0.982), e Over short-term testing, a small increase in outflow rate was observed as the ovary
rapidly absorbed fluid. Outflow rate subsequently began to level off as the tissue became saturated with fluid (Logarithmic trendline, R2 = 0.885).
Data presented as mean ± SE (n = 2)
Table 1 Flow rate and pH measurements of the media
Culture condition Mean ± SEM
Average Media Flow
Rate (mL/min)
Fresh media circulation (Group 1) 0.856 ± 0.023
DXR treatment in fresh media (Group 3) 0.880 ± 0.046
Average Media pH Fresh media circulation (Group 1) 7.72 ± 0.04
Recirculated media (Group 2) *6.27 ± 0.51
DXR treatment in fresh media (Group 3) 7.76 ± 0.14
Flow rates into the ovary were calculated from fresh media circulation (Group 1)
and 500 nM DXR treatments (Group 3) conditions. Flow rates are reported as bulk
averages taken over 6, 12 and 24 h time points to calculate the mean and SEM at
all time points. PH was measured from ovaries perfused with fresh media
(Group 1), recirculation of used media (Group 2), and DXR treatment of
fresh media (Group 3). Media was removed from the waste reservoir at 12, 24,
and 48 h time points to measure pH and determine the effect of the different
treatment groups on the bioreactor culture environment. Data presented as the
mean and SE across all time points
*p < 0.05, two-way ANOVA
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Cellular apoptosis during in vitro whole bovine culture
with and without DXR
The viability of ovaries over the course of study was mea-
sured using apoptotic markers. Specifically, ovaries in the
follicular stage with no visible corpora lutea were used to
assess apoptosis. Analysis of whole bovine determined that
upon harvest and receipt of the ovaries, the baseline apop-
totic cell percentage in fresh uncultured ovaries was 2.74
± 2.41 % (data not shown). TUNEL. TUNEL assay results
of the cultured ovaries exhibited an increase in apoptotic
cell percentages from baseline as time progressed for all
groups tested. The increase in apoptotic cells was, how-
ever, significantly reduced in ovaries cultured in continu-
ously supplied fresh media (Group 1) compared to
uncultured ovaries. The apoptotic cell percentage in the
control ovaries cultured in continuously supplied fresh
media (Group 1) was 2.2 ± 0.15 folds at 24 h and only
increased to 5.4 ± 0.9 folds after 48 h, which was not dif-
ferent from uncultured ovaries (Fig 3a/b and d). By com-
parison, the increase in apoptotic cell percentage was
greatest for the ovaries cultured in recirculated culture
media (Group 2) as these samples exhibited an 18.8 ± 2.4
folds (p < 0.001) higher apoptotic cell percentage at 24 h
when compared to control ovaries (Fig. 3d). This trend
was consistent at 48 h, as the apoptotic cell percentage in
the ovaries cultured in Group 2 increased to 27.9 ± 0.8
folds (p < 0.001) compared to control ovaries (Fig. 3c and
d), and exhibiting FITC/PI double stained cytoplasmic
granules at 96 h (arrows, Fig. 3c). This is likely due to the
decrease in the pH of the recirculated culture media as
noted in Table 1. Due to increase TUNEL-positive staining
in this culture model, further ovarian culture experiments
were performed using freshly circulated culture media
(groups 1 and 3). The continuous fresh media circulation
generated relatively low cell apoptosis during culture and
could, therefore, be used to determine if DXR treatment
affected cellular apoptosis. Ovaries cultured with DXR
treatment in continuous fresh media (Group 3) exhibited
an increase in apoptotic cell percentage from 11.4 ± 0.5
folds (p < 0.001) at 24 h to 17.2 ± 3.4 folds (p < 0.001) at
48 h when compared to control ovaries (Fig. 3A/B and D).
At both time points, the ovaries in the DXR treatment
group (Group 3) demonstrated greater apoptotic cell
percentages than ovaries that were similarly cultured in
continuous fresh media (Group 1), but less than that of
ovaries cultured in recirculated media in Group 2 (Fig. 3d).
Additional file 1: Figure S1 represents exemplar H&E
images of ovaries treated with DXR at 24 and 48 h.
Discussion
Currently, there is a paucity of in vitro models to test
the toxicity of chemotherapy drugs in the ovary. In this
study, we investigated the potential of a customized bio-
reactor to achieve extended in vitro whole bovine ovary
culture. The cow offers a useful model for human ovar-
ian disease due to the similarity of hormonal regulation
of the ovarian cycle [32]. Additionally, bovine ovaries are
readily available from slaughterhouses for minimal cost
as they are typically discarded. In vitro fertilization
procedures using oocytes harvested from bovine ovaries
have been perfected and used to study morphological
and molecular attributes of bovine embryo quality [33,
34]. This makes the bovine ovary a suitable model for
chemotherapy toxicity testing.
Great strides have been made through in vitro culture of
ovarian cells and tissue pieces/slices [32, 35, 36]. These
culture methods have long been a very useful tool for
studying reproductive functioning and toxicology. The
highly controlled conditions that these in vitro methods
provide offers insight to the mechanism of the toxico-
logical effects of drugs such as DXR. However, many ovar-
ian tissue cultures are not as advanced in that their
preparation causes them to lose the physiological crosstalk
they would have if the ovary remained whole. For this
reason, new methods have been developed to better repli-
cate an in vivo model while still maintaining a high level of
control. Three-dimensional culture approaches that
involve intact, 3D follicles have been developed and
improved upon in mice, nonhuman primates, and humans
to more accurately capture the important cell-cell
communication that influences ovarian and follicular func-
tioning [37–39]. Isolated follicle culture, however, fails to
preserve the unique structural and chemical environment
the entire ovary provides, in particular, the interplay be-
tween ovarian follicles and stroma. In this study, we
investigated the potential of a customized bioreactor to
achieve extended in vitro whole ovary culture. To the
authors’ knowledge, no method for prolonged in vitro
culture of mature, large animal ovaries currently exists.
Whole organ culture preserves the intricate interaction be-
tween somatic and germ cells, as well as recapitulates the
oocyte, follicle, and stroma interactions in a more compre-
hensive fashion. Additionally, whole ovary culture provides
the opportunity to assess ovarian connective tissue and
vasculature in their innate environment. Here, we effect-
ively utilized a vasculature-assisted method to distribute
nutrients throughout the entire ovary, providing an envir-
onment mimicking in vivo conditions while maintaining
low cellular apoptosis during culture. Additionally, the ease
of use and degree of control offered through our bioreactor
allows for quick and straightforward environment alter-
ation to enable use for different species. Thus, we conclude
that our system creates a suitable environment for success-
ful mature, whole bovine ovary culture as well as demon-
strates the potential use for studying the ovary, particularly
the effects of chemotherapy agents on the ovary.
The development of a system to efficiently deliver
nutrient to the entire organ is a fundamental piece to
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achieving successful whole ovary culture. To achieve
prolonged in vitro culture of follicles it is vital to ensure
nutrients reach the innermost of the ovary, which has a
rich vascular supply, to support growing follicles [3].
Other whole organ cultures, such as small mammal
ovary culture, recirculate media over the course of
culture [40]; however, this was observed to be ineffective
in whole bovine ovary culture. When media was recircu-
lated through the ovary a significant decrease in culture
media pH and apoptotic cells was observed, indicating
an extremely harsh culture environment. Here, we uti-
lized catheterization of the arteria ovarica to provide
Fig. 3 Analysis of cellular apoptosis after extended bovine ovary. a Representative confocal images of TUNEL staining in cultured whole bovine
ovaries treated with continuous fresh media with or without 500 nM DXR for 24 h and 48 h (Groups 1 and 3). b represent corresponding FITC
staining of the images shown in A. All treatment groups were fixed, stained using a TUNEL stain. TUNEL stain indicates cells that are undergoing
apoptosis (FITC, green) and Propidium iodide (PI, red) to show the nuclei. Examples of primordial and primary follicles are shown in images A-D,
antral follicles (F-H), and stroma (I to L). Control = ovaries cultured in continuous fresh media circulation, DXR = Doxorubicin. H = Hour,
scale bars = 100 μm for all images. Brightness was increased to +30 to enhance image visualization. c Representative images of TUNEL
staining of cultured whole bovine ovaries perfused with recirculated media at 0, 48, and 96 h (Group 2). A-C represents spectral composite
confocal images taken at 100X oil objective and D-I represent confocal images taken at 20X objective. All treatment groups were stained using
TUNEL assay. Control = uncultured ovaries. H = Hour, scale bars = 10 μm for the spectral composite confocal images (A-C). and 100 μm for the
confocal images (D-I). Brightness was increased to +30 to enhance image visualization. d Summary graph comparing cellular apoptosis after
extended culture of bovine ovaries perfused with continuous fresh media with or without 500 nM DXR (A/B), or with recirculated media (C). All
treatment groups were fixed, stained using a TUNEL stain and analyzed at 24 h and 48 h time points post-DXR treatment. TUNEL-positivity was
quantified in ovarian stroma and granulosa cells irrespective of follicle types. Single circulation fresh media (Group 1) demonstrated the lowest
level of cell apoptosis. DXR = Doxorubicin, H = Hour; n = 3 ovaries per treatment group, two-way ANOVA, ** p < 0.01; *** p < 0.001, n.s = non-significant
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nutrients throughout the ovary via the vasculature. This
method of catheterization has been previously used for
cryopreservation as well as for nutrient delivery to other
systems including the Langendorff heart [40]. In our
vascular-assisted perfusion model, only the prominent
branch of the ovarian arteries at the ovarian stump was
cannulated and perfused. Prior studies estimated bovine
ovarian blood flow rate at 1–3.2 mL/min depending
upon presence or absence of corpus luteum [41]. A flow
rate of 1.5 mL/min representing the median of the re-
ported range was used in our study.
After administering trypan blue dye to the ovary via
the vasculature at a constant flow rate, the ovary demon-
strated a gain in mass and outflow rate was initially
lower than inflow rate. The ovarian weight increased up
to 7.63 ± 3.1 g (~50 %) in the first 20 min. This is
equivalent to approximately 7500 μL of the medium be-
ing held in the ovary, indicating ovarian tissue absorbed
the delivered fluid prior to fluid diffusion spontaneously
out of the ovary. The initial increase in ovarian mass
may have occurred because fluid initially accumulated in
the ovarian interstitial space prior to diffusing freely out
of the ovary. Despite the increase in ovarian weight, this
did not appear to increase the percentage of apoptosis
when compared to uncultured ovaries. Over time, the
rate of mass increase slowed, as the tissue became satu-
rated and outflow rate nearly equaled inflow rate. These
observations mimic in vivo conditions previously de-
scribed [13, 16]. Flow rate results paralleled distribution
of dye through the vasculature and interstitial space of
the ovary, with dye staining most of the ovarian intersti-
tium tissue after 60 min. The observed variation in the
staining of the corpora lutea is likely due to the selective
cannulation of the most prominent ovarian artery
branch. As no rupture of the vasculature was observed
and the trypan blue dye appeared to travel smoothly
through the cannulated vasculature, we conclude this is
an effective method to deliver nutrients.
The chemotherapy drug, DXR, has well documented
negative effects, but the mechanism behind its toxicity is
not well understood. In order to elucidate the toxicity
mechanism, a more effective in vitro model is needed.
Thus, we examined the apoptotic effects of DXR, in order
to evaluate our system for chemotherapy toxicity testing.
DXR treatment demonstrated significant differences in
the percentage of apoptotic events seen between the DXR
(Group 3) and the group using the continuous fresh media
circulation (Group 1) provides preliminary validation that
this method will be useful for the study of ovarian tissue.
The DXR group had a substantial increase in apoptotic
events showing that altering the bioreactor culture condi-
tions changes the ovary tissue response. Adding DXR to
the culture media yielded a response consistent with
expectations [1, 10, 32] providing further evidence that
the bioreactor provides a controllable and reliable means
for media to interact with the entire ovary. Whole organs
respond to external factors differently than isolated
tissues. The method presented here appears to provide an
efficient way of studying how the whole ovary responds to
DXR while also mimicking the environment that the ovary
will experience in vivo. Further testing and optimization
of the chemical environment used for whole ovary culture
will elucidate the effectiveness of culture technique as well
as the potential for long-term whole ovary culture and will
allow assessment of the biological and functional
characterization of the system. Future studies will assess
longer periods of in vitro ovary culture to determine the
maximum duration that the ovary could maintain its via-
bility and the best time point to assess ovarian toxicity.
Since the bovine ovarian artery branches higher prior to
reaching the ovarian hilum, future studies will assess the
need to cannulate multiple ovarian artery branches in this
model. Standardization of the age and breed of the ani-
mals and the use of ovaries from young heifers is expected
to decrease tissue heterogeneity while allowing the assess-
ment of chemotherapy-induced ovarian toxicity and the
biological significance of morphological and molecular
changes in the ovary in greater detail. In this study, we
report apoptosis in stroma and granulosa cells without
reference to particular follicle types. Although we did
not quantify apoptosis per follicle type due to the het-
erogeneity of the tissue and lack of a sufficient num-
ber of different follicle types in some sections, general
apoptosis throughout the ovary was significantly in-
creased post-DXR treatment indicating the validity of
the model. Future studies will aim at a modified tech-
nique that includes serial sectioning of larger portions
of the bovine ovary in younger cows to capture ad-
equate numbers of various follicle types. This will
allow assessment of apoptosis per follicle type while
avoiding the repeated counting of preantral and antral
follicles which has an estimated diameter of 100 –
200 μM and 15–18 mm, respectively [42].
Conclusions
In summary, an effective method of culturing large
animal ovaries was developed and tested. The ovary
bioreactor system was shown to maintain low levels of
cellular apoptosis for at least 48 h of culture and
provided the ovary with necessary nutrients without
inflicting rupture of the perfused ovarian vasculature.
Methods described here not only provide a method for
large, mature ovary culture and study of follicular devel-
opment but also provide a method for drug screening.
Observing the effects of drugs, particularly chemother-
apy drugs, on the whole ovary will provide insights that
are not offered in traditional in vitro follicle cultures.
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Additional file
Additional file 1: Figure S1. Representative H&E staining of control
and DXR-treated whole bovine ovaries. Panels A-D display primordial
follicles, while panels E-H display antral follicles. Images E-H are an exact
replicate of the corresponding images in Fig. 3. Brightness was increased
to +30 to enhance image visualization. (TIF 43 mb)
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